ATTENUATION OF MUSCARINIC RECEPTOR-G-PROTEIN INTERACTION IN ALZHEIMER-DISEASE

被引:60
作者
FERRARIDILEO, G
MASH, DC
FLYNN, DD
机构
[1] UNIV MIAMI,SCH MED,DEPT MOLEC & CELLULAR PHARMACOL,MIAMI,FL 33101
[2] UNIV MIAMI,SCH MED,DEPT NEUROL,MIAMI,FL 33101
关键词
MI MUSCARINIC RECEPTORS; G-PROTEINS; GTP-GAMMA-S BINDING; GTP HYDROLYSIS; HUMAN BRAIN; ALZHEIMER DISEASE;
D O I
10.1007/BF03160113
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cortical M1 muscarinic receptor-G-protein coupling, high-affinity, guanine nucleotide-sensitive agonist binding (Flynn et al., 1991; Warpman et al., 1993) and muscarinic receptor-stimulated [H-3]PIP2 hydrolysis (Ferrari-DiLeo and Flynn, 1993) are known to be defective in Alzheimer disease. Whether this defect reflects an alteration in the M1 muscarinic receptor, its respective guanine nucleotide binding (G) protein or both is not known. This study compares the number and both basal and muscarinic receptor-mediated function of G-proteins in synaptosomal membranes from cerebral cortical samples of age-matched control subjects and Alzheimer disease patients. Immunoblotting with anti-G alpha(q/11) and anti-G beta antibodies demonstrated no alteration in the number of these G-protein subunits in Alzheimer disease. Basal [S-35]GTP gamma S binding and hydrolysis of [gamma-P-32]GTP by high-affinity GTPase also were not significantly altered in Alzheimer disease compared to control membrane samples. However, muscarinic agonist-stimulated GTP gamma S binding and GTP hydrolysis were significantly reduced (80-100%) in Alzheimer disease cortical samples. Diminished agonist-stimulated GTP gamma S binding and GTP hydrolysis correrelated with the loss of guanine nucleotide-sensitive, high-affinity agonist binding (K-L/K-H) ratio) to the M1 receptor subtype. These data provide further evidence for the loss of muscarinic receptor-G protein coupling in Alzheimer disease and support the hypothesis that muscarinic receptor-mediated cortical activation may be compromised in Alzheimer disease.
引用
收藏
页码:69 / 91
页数:23
相关论文
共 72 条
[1]  
ARAI H, 1992, PROG NEURO-PSYCHOPH, V16, P883
[2]   DIFFERENTIAL ALTERATION OF VARIOUS CHOLINERGIC MARKERS IN CORTICAL AND SUBCORTICAL REGIONS OF HUMAN-BRAIN IN ALZHEIMERS-DISEASE [J].
ARAUJO, DM ;
LAPCHAK, PA ;
ROBITAILLE, Y ;
GAUTHIER, S ;
QUIRION, R .
JOURNAL OF NEUROCHEMISTRY, 1988, 50 (06) :1914-1923
[3]   THE CHOLINERGIC HYPOTHESIS - A HISTORICAL OVERVIEW, CURRENT PERSPECTIVE, AND FUTURE-DIRECTIONS [J].
BARTUS, RT ;
DEAN, RL ;
PONTECORVO, MJ ;
FLICKER, C .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1985, 444 (MAY) :332-358
[4]   PHARMACOKINETICS AND PHARMACODYNAMICS OF ACETYLCHOLINESTERASE INHIBITION - CAN ACETYLCHOLINE LEVELS IN THE BRAIN BE IMPROVED IN ALZHEIMERS-DISEASE [J].
BECKER, RE ;
GIACOBINI, E .
DRUG DEVELOPMENT RESEARCH, 1988, 14 (3-4) :235-246
[5]   REGIONAL DISTRIBUTION OF SOMATOSTATIN RECEPTOR-BINDING AND MODULATION OF ADENYLYL CYCLASE ACTIVITY IN ALZHEIMERS-DISEASE BRAIN [J].
BERGSTROM, L ;
GARLIND, A ;
NILSSON, L ;
ALAFUZOFF, I ;
FOWLER, CJ ;
WINBLAD, B ;
COWBURN, RF .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1991, 105 (02) :225-233
[6]  
BERNSTEIN G, 1992, J BIOL CHEM, V267, P8081
[7]   A RAPID, SENSITIVE METHOD FOR DETECTION OF ALKALINE-PHOSPHATASE CONJUGATED ANTI-ANTIBODY ON WESTERN BLOTS [J].
BLAKE, MS ;
JOHNSTON, KH ;
RUSSELLJONES, GJ ;
GOTSCHLICH, EC .
ANALYTICAL BIOCHEMISTRY, 1984, 136 (01) :175-179
[8]  
BLANK JL, 1991, J BIOL CHEM, V266, P18206
[9]   DISEASE STATES CAN MODIFY BOTH RECEPTOR NUMBER AND SIGNAL TRANSDUCTION PATHWAYS [J].
BRODDE, OE ;
MICHEL, MC .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1989, 10 (10) :383-384
[10]   PROCESSING OF ALZHEIMER BETA-A4 AMYLOID PRECURSOR PROTEIN - MODULATION BY AGENTS THAT REGULATE PROTEIN-PHOSPHORYLATION [J].
BUXBAUM, JD ;
GANDY, SE ;
CICCHETTI, P ;
EHRLICH, ME ;
CZERNIK, AJ ;
FRACASSO, RP ;
RAMABHADRAN, TV ;
UNTERBECK, AJ ;
GREENGARD, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (15) :6003-6006